Journal of Pharmacological and Toxicological Methods

Papers
(The median citation count of Journal of Pharmacological and Toxicological Methods is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Editorial Board35
A personal reflection on 23 years of the Journal of pharmacological and toxicological methods32
Quantitative comparison of ECG limb lead configurations: Evaluating synonymity of interval measurements using alternative leads under appropriately controlled study conditions25
Off-target of a novel TYK2 inhibitor is associated with myocardial necrosis mediated by hemodynamic changes in rats21
Reproducible safety pharmacology echocardiography studies in vehicle-treated canines and NHPs21
Predicting human cardiac QT alterations and pro-arrhythmic effects of compounds with a 3D beating heart-on-chip platform20
Organelle profiling of compound-induced effects in human iPSC-derived cardiomyocytes in combination with electrophysiology assays for in vitro prediction of cardiac safety18
The impact of collaborative science on cardiovascular safety evaluation – A 10-year update of the HESI cardiac safety committee17
Assessment of abuse liability and respiratory effects of mitragynine and 7-hydroxymitragynine in rats16
A retrospective analysis of the concordance between cardiovascular effects in telemetry studies, toxicity studies, and early clinical trials15
Corrigendum to ‘PolyCheck: A hybrid model for predicting polypharmacy-induced adverse drug reactions in tuberculosis treatment using heterogenous drug-target-ADR networks’ [Journal of pharmacological 15
Contractility assessment using aligned human iPSC-derived cardiomyocytes12
Development of simultaneous determination of dopamine 2, histamine 1, and muscarinic acetylcholine receptor occupancies by antipsychotics using liquid chromatography with tandem mass spectrometry12
Metabolomics using high-resolution magic angle spinning nuclear magnetic resonance: Neurotoxicological applications12
Comparison of cell viability methods for human mesenchymal/stromal stem cells and human A549 lung carcinoma cells after freeze-thaw stress12
Ciprofloxacin does not accelerate aortic stiffness or aortic dilation in healthy, hypertensive and diseased mouse models11
Overview of the bioanalytical methods used for the determination of benzodiazepines in biological samples and their suitability for emergency toxicological analysis11
hiPSC-derived neurons and multi-electrode array (MEA): Powerful tools within safety pharmacology for identifying the CNS modifying effects of compounds targeting ligand- and voltage-gated ion channels11
Optimization of an method for assessing pulmonary permeability of inhaled drugs using alveolar epithelial cells11
Investigation of in vitro I /hERG assays under physiological temperature conditions using the semi-automated patch-clamp system QPatch compact with temperature control system10
Effects of temperature, compound concentration verification, and internal fluoride on hERG9
In silico modelling of stroke volume, cardiac output and systemic vascular resistance in cardiovascular safety pharmacology studies by telemetry9
Retrospective review of the safety pharmacology assessment of emerging therapeutic modalities approved from 2010 to 20239
Enhanced detection sensitivity in nonclinical cardiovascular telemetry studies: Impact of a characterized facility9
Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translation9
The visual field-testing maze and vision maze: Feasible techniques to evaluate visual field loss in animals9
Enhanced interpretation of secondary pharmacology data through automated visualization tools to support safety assessment9
Less invasive, simultaneous, and continuous measurements of locomotor activity and body temperature using the nano tag® small accelerometer device in cynomolgus monkeys9
Development and validation of a sensitive LC-MS/MS assay for determination of upadacitinib in human plasma and its application in patients with inflammatory bowel disease8
Development of electrophysiological toxicity assay system with iPSC-derived GABAergic neurons generated by a rapid differentiation method8
Advances in microfluidic endothelium-on-chip for assessing endothelial function8
An investigation into the relationship between acetazolamide systemic exposure, blood gas changes and ventilatory parameters in the sprague Dawley® rat8
Effect of telemetry study design on minimum detectable difference values for QTc interval8
Predicting clinical outcomes from off-target receptor interactions using Secondary Intelligence™8
Monitoring cardiomyocyte function with hybrid EFP-impedance technology for drug safety evaluation8
In-situ polyherbal gel as biomedicine in the management of Alzheimer's disease: Understanding ameliorative potential in Trimethyltin induced neurodegeneration8
Comparisons of hERG data for 30 drugs generated by automated and manual patch clamp systems by the same laboratory7
Analyzing atrial human iPSC-cardiomyocyte responses to GPCR and ion channel modulators: Introducing a chamber-specific cell model for preclinical testing7
Evaluation of the J-Tpeak and Tpeak-to-tend intervals of the ECG as proarrhythmia biomarkers in telemetered dogs7
Comparison of quinine-induced QRS prolongation in canine and primate telemetry studies: Applying concentration-effect modeling to assess ventricular conduction delay risk7
Minimal requirements for stem-cells derived cardiomyocytes and MEA usage in view of field potential analysis by reverse modeling - A theoretical study on the impact of 3 variability factors6
Optimized J to T peak and T peak to T end measurements in nonclinical species administered moxifloxacin and amiodarone6
In-house fabrication of bipolar electrode-cannula assembly for electrical stimulation and drug delivery at the same site in rat brain6
Gene therapy: A different challenge for toxicologists?6
Streamlined dispersive solid phase extraction for determination of amitriptyline, cocaine, and benzoylecgonine in urine6
Meeting abstracts, Eighteenth Annual Themed Issue on Methods in Safety Pharmacology6
Non-invasive monitoring of cardiac output: Validation in anesthetized laboratory rats by pharmacological beta-adrenergic pathway modulation6
Development and validation of an LC-MSMS method for the quantitation of pacritinib; application of kinetics in rabbits6
Analytical method development for detection and quantification of AMB-FUBINACA in mouse brain tissue using GC–MS/MS5
The translation of hERG block and APD90 in vitro to clinical QTc prolongation in man5
Regulatory safety pharmacology & toxicology assessment studies: Measurement of the ECG and hemodynamic parameters in non-rodent species5
Exploratory safety investigations in normal, freely moving Göttingen Minipigs using telemetry: Pharmacological validation5
Performance and feasibility of three different approaches for computer based semi-automated analysis of ventricular arrhythmias in telemetric long-term ECG in cynomolgus monkeys5
Are current rat studies sensitive to detect blood pressure changes per the new FDA draft clinical blood pressure guidance?5
In silico modeling of hemodynamic and autonomic effects of a selective α2-adrenoceptor agonist in beagle dogs by telemetry5
Editorial Board5
Reference intervals and method sensitivity for electrocardiology, hemodynamics, and body temperature parameters in healthy cynomolgus monkeys5
QT Ratio: A simple solution to individual QT correction5
Taking a deep breath: Evidence-based approaches to respiratory safety assessment5
Neural network emulation of the human ventricular cardiomyocyte action potential: A promising tool for more efficient computations in quantitative systems pharmacology studies5
Analytical performance of poly(L-cysteine) modified pencil graphite electrode for dapsone detection5
Editorial Board5
Non-clinical cardiovascular safety testing: Current status, gaps and emerging trends4
Establishment of high-throughput toxicity assay system with iPSC-derived GABAergic neurons generated by a rapid differentiation method4
Establishment of functional observational battery test in large animals (dogs and non-human primates)4
In silico modeling of effects of pimobendan on cardiac output and systemic vascular resistance in beagle dogs by telemetry4
Serum starvation magnifies the delayed suppression of IK by probucol4
Recording of transcellular voltage deflections from cardiomyocytes on MEA devices using laser poration4
Improving on-tissue detection of doxorubicin by using matrix assisted laser desorption ionization mass spectrometry imaging4
An in silico approach during safety pharmacology studies4
Using automated patch clamp for high throughput pharmacological characterization of cardiac action potentials4
Evaluation of the head twitch response in male C57BL/6J mice as a measure of 5-HT receptor activation4
Development of spectroscopic methods using charge transfer complex for the quantitative estimation of proguanil hydrochloride: Insights from greenness evaluation, BSA binding, molecular docking, antim3
Evaluation of the translation of multiple cardiovascular regulatory mechanisms in the anesthetized dog3
High-throughput evaluation of cardiac electrophysiology and predicted actions on cardiac ion channels using hiPSC-CM and MEA technology3
Assessing the cardiotoxicity of 31 compounds using a multiplexed kinetic image cytometry (KIC)-based assay: Harnessing the predictive power of human iPSC-cardiomyocytes for early drug development3
Computational modelling for improved translation of cardiac inotropic and lusitropic drug effects from rats to humans3
A retrospective review of the effects of moxifloxacin in NHP at four different test sites3
Study to compare effects of a positive inotrope administered concurrently with a beta-blocker in ventricular Tachy-Paced dogs in mild heart failure3
Comparison of validity of standard nonclinical group size selection versus standard clinical group sizes for nonhuman primate QTc prolongation evaluation3
Ultra-fast UPLC–MS/MS approach for estimating X-376 in human liver microsomes: Evaluation of metabolic stability via in silico software and in vitro analysis3
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As3
Editorial Board3
Variability of manual patch clamp hERG data generated using standardized protocols and following ICH S7B Q&A 2.1 best practices3
Species comparison of compounds with known blood pressure effects in a vascular smooth muscle cell collagen contraction assay3
Enhancing cardiac safety evaluation: Assessing drug interactions with the late Nav1.5 current3
Protein malnutrition in BALB/C mice: A model mimicking clinical scenario of marasmic-kwashiorkor malnutrition3
Development of a novel milli-fluidic liver tissue chip for mechanistic drug-induced liver injury (DILI) studies2
Multi-site validation of in vivo QT ICH E14/S7B Q&A guidance in canines and non-human primates2
Editorial Board2
Correlation electrical repolarization and membrane hERG abundance in iPSC cardiomyocytes induced by chronic drugs actions on channel trafficking2
Molecular imaging of excitability difference between alkaloids/salts (nicotine, nicotinic benzoate, caffeine and arecoline hydrobromide)2
Elucidating the challenges with categorizing drugs that block cardiac sodium channels − The impact of temperature on drug-cardiac sodium channel interactions2
Combination of quadrupole isotope dilution mass spectrometry with simultaneous derivatization and spray assisted droplet formation-liquid phase microextraction for the determination of methamphetamine2
Discovery and development of digital biomarkers to inform home-cage neuro-behavioral assessments in the rodent2
Stress-free blood sampling in minipigs: A novel method for assessing 24-h cortisol profiles and drug effects on diurnal and ultradian rhythms2
Collaborative science in action: A 20 year perspective from the Health and Environmental Sciences Institute (HESI) Cardiac Safety Committee2
Effects of species of origin and mode of induction of microsomes on carbamazepine-induced cell toxicity2
Safety pharmacology 2023 and implementation of the ICH E14/S7B Q&A guidance document2
A general and rapid LC-MS/MS method for simultaneous determination of voriconazole, posaconazole, fluconazole, itraconazole and hydroxyitraconazole in IFI patients2
Dog and minipig telemetry assay sensitivity to detect QTc prolongation: Moxifloxacin effects by timepoint and concentration-QTc relationship analysis2
Novel method for determination of colistin sulfate in human plasma by high-performance liquid chromatography-tandem mass spectrometry and its clinical applications in critically ill patients2
QTc least significant difference in stand-alone implanted telemetry safety pharmacology and jacketed external telemetry regulatory toxicology studies in dogs2
Identification of gene expression change associated with isoflurane anesthesia and neurocognitive disorders using bioinformatics methods2
Spectrum of effects detected in the rat functional observational battery following administration of non-CNS targeted and CNS targeted compounds2
Electrocardiography and heart rate variability in Göttingen Minipigs: Impact of diurnal variation, lead placement, repeatability and streptozotocin-induced diabetes2
State-of-the-art in secondary pharmacology and its impact on the safety of new medicines2
Lipopolysaccharide-induced abdominal nociception behavioral model in adult zebrafish (Danio rerio)2
Therapeutic drug monitoring of busulfan and cyclophosphamide in hematologic malignancies: An LC-MS/MS development, validation and application2
Long-term monitoring of cardiac action potentials for the assessment of chronic cardiotoxicity2
Rapid quantification of CSF total protein via smartphone digital colorimetry: Enabling early diagnosis of central nervous system diseases2
Combining a systems immunology approach with in vitro data to evaluate drug-induced changes in the immune response after Influenza A Virus infection – A blueprint for the preclinical assessment of inf2
Cardiac 3D electromechanical tissue simulations for cardiac safety analysis2
ICH E14/S7B Q&A integrated risk assessment: Strategies for managing TQT waivers if S7B non-clinical studies don't meet best practice expectations2
Development of a pharmaceutical database to support the nonclinical evaluation of drug-induced cardiac toxicity2
Thirty years of telemetry-based data acquisition for cardiovascular drug safety evaluation: Applications and optimization2
Current practices on the measurement of electrocardiogram and hemodynamic parameters in non–rodent species in regulatory safety assessment studies2
A translational study between human induced pluripotent stem cell-derived cardiomyocytes (Hipsc-Cm) and an in vivo model to predict proarrhythmogenic properties2
In silico predictions of drug-induced changes on cardiac contractility in human ventricular cardiomyocytes2
Validation of an LC–MS/MS method for quantitation of fostemsavir in plasma2
Virtual clinical QT exposure-response studies – A translational computational approach2
Heart rate corrected JTp and TpTe as proarrhythmia biomarkers in safety pharmacology non-human primate studies: Outcome from a HESI consortium prospective study1
Recommendations on the measurement of electrocardiogram and hemodynamic parameters in restrained non-rodent species in regulatory safety assessment studies1
hERG block potencies for 5 positive control drugs obtained per ICH E14/S7B Q&As best practices: Impact of recording temperature and drug loss1
Action potential recordings from air-shipped adult human primary cardiomyocytes1
Non invasive jacketed telemetry in socially-housed rats for a combined assessment of respiratory system, electrocardiogram and activity using the DECRO system1
Editorial Board1
Editorial Board1
Evaluation of laser optoporation-induced action-potential-like measurements on iPSC-cardiomyocytes and the assessment of drug-induced effects on APD and contractility1
Non-invasive, home cage digital monitoring for improved safety pharmacology assessments in drug development: ICH S7A update considerations1
Long-term inhibition of PI3K/Akt signaling by amiodarone augments late sodium current in CHO cells and hiPSC-CMs1
Intravenous self-administration in the rat: Advantage of transcutaneous buttons for improving the animal welfare1
Enhancing the functional maturity of hiPSC-derived cardiomyocytes to assess inotropic compounds1
Cardiac injury miRNA profile in breast cancer patients treated with left-sided radiotherapy1
Editorial Board1
Pharmacological assessments of NaV1.5 and hERG channel blockers in AV-ablated isolated rabbit heart assay under varying heart rates and temperatures1
Importance of beating rate control for the analysis of drug effects on contractility in human induced pluripotent stem cell-derived cardiomyocytes1
A retrospective review of the effects of moxifloxacin in dogs at four different test sites1
Angiotensin II as a linking factor in cardiovascular disease enhanced cancer growth1
hERG agonists pose challenges to web-based machine learning methods for prediction of drug-hERG channel interaction1
Off-target pharmacological activity at various kinases: Potential functional and pathological side effects1
Adding artificial arrhythmias during training boosts the performance of neuronal networks for arrhythmia detection1
Chemometrics-assisted spectrophotometric method for the simultaneous determination of phenylephrine hydrochloride, chlorpheniramine maleate and paracetamol1
Fun with pharmacology: Evaluating stresses on the system using the core battery1
Compound A, a novel dual mu and kappa opioid receptor agonist that exerts potent an analgesic effect comparable to oxycodone, showed no reinforcing effect in monkeys1
WITHDRAWN: Simultaneous quantification of venetoclax, busulfan and voriconazole in plasma by LC-MS/MS: clinical applications in patients with acute myeloid leukemia1
An evaluation of detection sensitivity and pharmacokinetic profile for conscious telemetered cynomolgus monkeys1
A comparative study of kidney lithogenic agents in Wistar rats by invasive and noninvasive methods1
PolyCheck: A hybrid model for predicting polypharmacy-induced adverse drug reactions in tuberculosis treatment using heterogenous drug-target-ADR networks1
Best practice considerations for nonclinical in vivo cardiovascular telemetry studies with alternative study designs in non-rodent species1
Toxicology and safety pharmacology investigations on the nervous system: 2024 industry survey1
Test facility management: Responsibilities and paradigms of a new era1
A state-of-the-art method for high-throughput, automated locomotor activity testing in neuropharmacology, safety, and toxicology studies1
Characterization of a human wearable ECG device for continuous in-cage data collection in non-rodents1
Rodent models of anxiety and compulsion: When multiple endpoints add value1
The role of the central amygdala in threat response in a semi-natural environment1
Predicting thorough QT safety profile using hERG IC10 versus IC501
Editorial Board1
An ex vivo zebrafish heart model for oxidative stress studies1
Non-uniformity in in vitro drug-induced cytotoxicity as evidenced by differences in IC50 values – implications and way forward1
Astrocyte responses to seizurogenic compounds using MEA1
Detecting drug-induced EEG alterations with machine learning: A methodological proof-of-concept study in rats treated with MK-8011
In vitro systems for the assessment of chronic cardiotoxic effects: News from the HESI stem cell working group1
An accurate and reproducible method to measure snake venom anticoagulant activity1
Inter-rater agreement between WHO- Uppsala Monitoring Centre system and Naranjo algorithm for causality assessment of adverse drug reactions1
Improved translation of Nav1.5 channel inhibition to in vivo QRS interval prolongation via the hIPSC cardiomyocyte model1
Snapshot versus continuous analysis of respiratory parameters collected by whole body plethysmography following oral administration of caffeine and baclofen in conscious unrestrained rats1
Evaluating the proarrhythmic risk of delayed-action compounds in serum free cell culture conditions; serum-starvation accelerates/amplifies the effect of probucol on the KCNQ1 + KCNE1 channel1
Using cultured human myocardial tissue slices to test cardiotoxic effects1
Nonclinical pharmacokinetics of E3112, a recombinant human hepatocyte growth factor, in rats and monkeys by a simple ELISA kit assay1
Surgical instrumentation of cardiovascular telemetry device has minimal impact on the general toxicology data interpretation in Cynomolgus monkeys1
Categorizing TdP risk with qNet: Effects of protocol design on HERG models and TMS outcomes1
High-content cell imaging for chemical toxicity screening in the model organism Caenorhabditis elegans1
Drug combination assays using Caenorhabditis elegans as a model system1
The translation of QTc across species - Impact of subject number and exposure multiple tested on discriminatory sensitivity1
StemRNA iPSC-derived human ventricular cardiac tissue (iHCT) for safety pharmacology assessment1
Physiologically relevant in vitro endothelial model for studying drug-induced vascular injury0
Editorial Board0
Changes in the nerve conduction (NC) of juvenile rodents due to maturation with implications for preclinical evaluation of toxic neuropathies0
Safety Pharmacology: Achieving a quarter century milestone as a scientific discipline0
Development of a label-free cytotoxicity assay for dose response analysis0
Video-based detection of pentylenetetrazol induced severe convulsions in cynomolgus monkeys0
Comparison of electrocardiogram and blood pressure recording methods in non-rodent toxicology studies: A retrospective analysis0
Development of drug toxicity evaluation platform using hiPSC-derived cardiac organoids0
Artificial intelligence-based phenotypic characterization of gender-specific, patient – iPSC derived cardiomyocyte cell models0
Revisiting the high-fat diet/low streptozotocin prediabetic rat model: A bioanalytical adjustment0
Optimization of bioanalysis of dried blood samples0
Exploratory continuous interstitial glucose monitoring using the FreeStyle Libre 2 device in cynomolgus monkeys0
Simultaneous quantification of thalidomide, lenalidomide and pomadomide in plasma by LC-MS/MS0
Physiologic corrections for ECG intervals beyond QT0
High throughput automated patch-clamp of cardiac ion channels using physiological fluoride-free internal solution0
OCT2 in the heart and GAT1 in the brain: Functional characterization and drug development using SSM-based electrophysiology0
Application for drug evaluation of human-induced pluripotent stem cell-derived cardiomyocytes cultured by anisotropic orientation0
A simple, accurate method for defining concentration-QTc in animals0
Analysis of secondary pharmacology assays received by the US Food and Drug Administration0
Evaluation of the sensitivity/specificity of statistical analysis strategies for detecting moxifloxacin-induced QTc prolongation0
Redefining cardiovascular safety: A dual-pathway, mechanistic in silico screen for the detection of trafficking-mediated and “hidden” cardiotoxicity0
JET, but not ‘snapshot’, analysis is sensitive enough to detect effects at critical concentrations of ondansetron and moxifloxacin in dog0
Editorial Board0
Prediction of postural hypotension in humans from α -adrenoceptor binding data using secondary intelligence™0
Anticoagulant activity of Eucalyptus essential oils: An in vitro approach and a bioinformatics-based pharmacokinetic-pharmacodynamic analysis0
Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions.0
Corrigendum to “Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As” [J. Pharm0
Effects of high-fat diet and nutraceutical resveratrol on maximal force, power and fatigue resistance of skeletal muscle0
A genetic algorithm-based approach for the prediction of metabolic drug-drug interactions involving CYP2C8 or CYP2B60
In vitro assessment of long-term cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes0
An optimized method for intratracheal instillation in mice0
Functional observation battery (FOB)/Irwin integrated in general toxicology studies: A retrospective analysis0
The application of Bayesian forecasting to explore the effects of sex and high-fat diet on the pharmacokinetics of ropivacaine in the rat0
A characterization of aficamten, a cardiac myosin inhibitor, in core battery safety pharmacology studies0
Adaptation of closed-chest infarction porcine model to adult Pannon minipigs0
An iPSC-derived neurotoxicity screening platform demonstrates compound toxicity on calcium activity, synapses, viability and cell proliferation0
Development of a high-throughput system for advanced functional cell analysis to predict safety0
Telemetry in toxicology studies – A comparison of data across species, technologies and time0
Evaluating mitochondrial dysfunction and hepatotoxicity in HUREL micro liver co-cultures0
Panelizing secondary pharmacology profiling against key safety liabilities to further impact drug development0
The 2023 Safety Pharmacology Society (SPS) salary survey0
Editorial Board0
Quantitative framework for using in vitro hERG IC s to support integrated nonclinical risk assessment for the new ICH E14/S7B Q&As0
Preclinical mitigation of 5-HT2B agonism-related cardiac valvulopathy revisited0
High-throughput drug screening of 3D hiPSC cardiac microtissues with inherited arrhythmia disorders to identify novel therapeutic compounds0
From surplus to scientific value: Repurposing vascular tissues for organ bath standardization to de-risk vasoactive liabilities0
Effects of fentanyl on respiratory and cardiovascular systems in telemetered monkeys0
Characterization of a human wearable ECG device for continuous data collection in freely moving non-rodents0
Chronic assessment of hERG trafficking on repolarisation and cytotoxicity in iPSC cardiomyocytes0
The emerging use of artificial intelligence in safety pharmacology and toxicology0
Amphetamine, methamphetamine, and MDMA in hair samples from a rehabilitation facility: Validation and applicability of HF-LPME-GC-MS0
Improved seizure liability detection by combining rat hippocampal brain slice electrophysiology with in vivo behavior observation following intracerebroventricular drug administration0
ICH S7B hERG and cardiac repolarization assays do not address mechanisms of QT prolongation for peptide and protein products0
HERG block in HEK cells incorporated in real time into computer models of in silico cardiac repolarization using dynamic clamp0
Improving the in Vivo QTc assay: The value of implementing best practices to support an integrated nonclinical-clinical QTc risk assessment and TQT substitute0
Contractility-based pharmacological characterization of hiPSC-derived atrial and ventricular cardiomyocytes assessed on the FLEXcyte 960
Phenylthiourea-mediated experimental depigmentation reduces seizurogenic response of pentylenetetrazol in zebrafish larva0
Assay development and validation to measure contraction force from co-culture of human iPSC-derived cardiomyocytes and cardiac fibroblasts on the FLEXcyte 96 system0
From cellular waste to biomarkers; insights into past, present, and future methods to detect immune cell-derived extracellular vesicles using flow cytometry0
Regulatory feedback on drug discrimination studies for a small molecule with a novel mechanism of action0
Cardiovascular assessment of lipid nanoparticle-encapsulating mRNA therapeutics in rats using telemetry and Star-Oddi logger devices0
Cardiovascular effects of Zenalpha® compared to dexmedetomidine in ventricular tachy-paced dogs0
From neat compounds to complex mixtures: A potential screening strategy for cardiotoxic potential of botanicals0
Comparative toxicity assessment of selected nanoparticles using different experimental model organisms0
Intravenous self-administration – Valid experimental designs to evaluate the abuse potential of psychedelics, entactogens and drugs with novel mechanisms0
Analysis of baroreflex and heart rate variability – Tools in cardiovascular pre-clinical safety studies0
A simple accurate method for concentration-QTc analysis in preclinical animal models0
Compromising the immunogenicity of diphtheria toxin-based immunotoxins through epitope engineering: An in silico approach0
Editorial Board0
Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment0
Assessment moxifloxacin-induced QTc prolongation in canine and nonhuman primate using a linear mixed effect modeling approach0
High-throughput assessment of cardiac safety via calcium and voltage imaging of 3D engineered heart tissues and 2D cell cultures using a novel instrumentation platform0
Reference intervals for electrocardiograms and arrhythmia incidence in healthy, sedated cynomolgus macaques0
Surgical instrumentation for concomitant systemic blood pressure and blood sampling in healthy rabbits0
0.86229300498962